LOTEMAX 0.5 %
LOTEPREDNOL ETABONATE : 0.5 % · DIN 02321114 · BAUSCH & LOMB INC
Health Canada status: MARKETED
What is LOTEMAX?
LOTEMAX 0.5 % contains LOTEPREDNOL ETABONATE : 0.5 %. It is listed in the Health Canada Drug Product Database under DIN 02321114, held by BAUSCH & LOMB INC, supplied as SUSPENSION for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 24-Jun-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LOTEMAX used for?
Treatment of post-operative inflammation following cataract surgery.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02321114 |
|---|---|
| Brand name | LOTEMAX |
| Generic / active ingredient | LOTEPREDNOL ETABONATE : 0.5 % |
| Manufacturer | BAUSCH & LOMB INC |
| Strength | 0.5 % |
| Dosage form | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01BA14 LOTEPREDNOL |
| AHFS class | 52:08.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Jun-2009 |
| Original market date | 2009-06-24 00:00:00 |
How is it administered?
Apply 1-2 drops into the conjunctival sac of the operated eye(s) 4 times daily starting 24 hours after surgery for 2 weeks. Shake vigorously before using.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store upright between 15°–25°C (59°–77°F). Do not freeze. Use within 28 days after opening.
How is it supplied?
White LDPE bottles with controlled drop tip and pink cap in sizes: 2.5 mL, 5 mL, 10 mL, and 15 mL.
Contraindications
Suspected/confirmed viral, mycobacterial, or fungal eye infections (e.g., herpes simplex, vaccinia, varicella). Hypersensitivity to loteprednol etabonate, other corticosteroids, or any ingredient.
Warnings and precautions
Short-term use only (up to 14 days). Monitor IOP if used >10 days. May delay wound healing, cause cataracts/glaucoma, or mask/exacerbate infections. Contains benzalkonium chloride.
What can be used instead?
Other Canadian products sharing ATC code S01BA14 LOTEPREDNOL. 4 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALREX | 0.2 % | SUSPENSION | BAUSCH & LOMB INC | MARKETED | DIN 02320924 |
| LOTEMAX GEL | 0.5 % | GEL | BAUSCH & LOMB INC | MARKETED | DIN 02435853 |
| LOTEMAX OINTMENT | 0.5 % | OINTMENT | BAUSCH & LOMB INC | MARKETED | DIN 02421941 |
Who else supplies LOTEPREDNOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LOTEPREDNOL appears in 17 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.